CN1160055C - External-use bathing lotion with antibiotic and anti-inflammatory functions - Google Patents
External-use bathing lotion with antibiotic and anti-inflammatory functions Download PDFInfo
- Publication number
- CN1160055C CN1160055C CNB981223494A CN98122349A CN1160055C CN 1160055 C CN1160055 C CN 1160055C CN B981223494 A CNB981223494 A CN B981223494A CN 98122349 A CN98122349 A CN 98122349A CN 1160055 C CN1160055 C CN 1160055C
- Authority
- CN
- China
- Prior art keywords
- bath
- alumen
- mentholum
- bath powder
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003287 bathing Methods 0.000 title claims description 7
- 239000006210 lotion Substances 0.000 title claims description 6
- 230000003110 anti-inflammatory effect Effects 0.000 title description 5
- 230000006870 function Effects 0.000 title description 5
- 230000003115 biocidal effect Effects 0.000 title 1
- 239000000843 powder Substances 0.000 claims abstract description 30
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 30
- 206010061218 Inflammation Diseases 0.000 claims description 10
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- 239000013040 bath agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 abstract description 29
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 19
- 241000228143 Penicillium Species 0.000 abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 241000222122 Candida albicans Species 0.000 abstract description 9
- 241001299895 Microsporum ferrugineum Species 0.000 abstract description 9
- 241000191963 Staphylococcus epidermidis Species 0.000 abstract description 9
- 229940095731 candida albicans Drugs 0.000 abstract description 9
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 8
- 208000017520 skin disease Diseases 0.000 abstract description 8
- 241001149963 Sporothrix schenckii Species 0.000 abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 230000001954 sterilising effect Effects 0.000 abstract description 6
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 241000893976 Nannizzia gypsea Species 0.000 abstract description 2
- 238000007654 immersion Methods 0.000 abstract description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 abstract 1
- 201000007336 Cryptococcosis Diseases 0.000 abstract 1
- 241000221204 Cryptococcus neoformans Species 0.000 abstract 1
- 241001480036 Epidermophyton floccosum Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 235000020737 peppermint extract Nutrition 0.000 abstract 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 33
- 244000048199 Hibiscus mutabilis Species 0.000 description 23
- 230000000694 effects Effects 0.000 description 20
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000000203 mixture Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 201000004624 Dermatitis Diseases 0.000 description 10
- 241000588769 Proteus <enterobacteria> Species 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 244000063299 Bacillus subtilis Species 0.000 description 7
- 235000014469 Bacillus subtilis Nutrition 0.000 description 7
- 241001337994 Cryptococcus <scale insect> Species 0.000 description 7
- 241000233866 Fungi Species 0.000 description 7
- 210000001072 colon Anatomy 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 238000007598 dipping method Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000002538 fungal effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 206010012504 Dermatophytosis Diseases 0.000 description 4
- 206010048768 Dermatosis Diseases 0.000 description 4
- 206010018612 Gonorrhoea Diseases 0.000 description 4
- 241001460074 Microsporum distortum Species 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000228150 Penicillium chrysogenum Species 0.000 description 4
- 241000228153 Penicillium citrinum Species 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000001786 gonorrhea Diseases 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 241001480043 Arthrodermataceae Species 0.000 description 3
- 230000001139 anti-pruritic effect Effects 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000037304 dermatophytes Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000193738 Bacillus anthracis Species 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- 208000019872 Drug Eruptions Diseases 0.000 description 2
- 206010037083 Prurigo Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 206010035114 pityriasis rosea Diseases 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- -1 sulfuric acid aluminum potassium Chemical compound 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000000143 urethritis Diseases 0.000 description 2
- 208000002003 vulvitis Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000589562 Brucella Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 239000006159 Sabouraud's agar Substances 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 241000710961 Semliki Forest virus Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 241001312524 Streptococcus viridans Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003716 antitrichomonal agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical group OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 231100000668 minimum lethal dose Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to external bath powder, particularly to Huafu bath powder composed of alum (hydrous aluminium potassium sulfate) as a traditional Chinese medicine, and peppermint extract (containing peppermint camphor). The bath powder can be dissolved in warm water to achieve the purposes of skin disinfection and skin sterilization through an immersion bath or a shower bath, and the bath powder is suitable for the adjuvant therapy of various skin diseases. The product performs significant sterilization action on Candida albicans, cryptococcus neoformans, sporotrichum schenckii, epidermophyton floccosum, microsporum gypseum, microsporum ferrugineum, staphylococcus aureus, staphylococcus epidermidis, escherichia coli, protei, hay bacillus and penicillium.
Description
A kind of external-use bathing lotion---magnificent cottonrose hibiscus bath powder with anti-inflammation, be applicable to clinical bacterial skin infections, fungal infection and various diseases associated with inflammation, particularly to skin lesion widely disease such as subacute or chronic eczema, general scratch where it itches that disease, rubescent dermatitis or eczema, pruritus, drug eruption, prurigo, pityriasis rosea, urethritis, scrotitis, vulvitis, gonorrhea and the non-gonorrhea sexuality of diffusivity are dyed, perianal dermatitis, perineal position dermatitis, eczema etc. and psoriatic stable phase and preferable curative effect is all arranged paracmasis.
China's cottonrose hibiscus bath powder is to treat one group of compound Chinese medicinal preparation that various dermatosiss inspire design according to immersion to boil water of motherland's medical use Chinese medicine or shower.Existing hundreds of years history of dipping development of motherland's medical science, some dermatosis was also produced certain obvious curative effects, but because the ingredient instability of various dippings, or because the dipping time is short, drug level is low, therapeutic effect is limited, some medicine is Diazolidinyl Urea or sensitization also, even can and cause the whole body poisoning through the skin absorption, therefore, seek the externally used antimicrobial antiinflammatory of some high-efficiency low-toxicities and bathe agent, be pharmacy worker heat subject anxious to be solved always.
The purpose of this invention is to provide a kind of antibacterial and anti-inflammation functions that has, but skin is not had toxic external-use bathing lotion, this bath agent can be used for the control of various dermatosis.
The object of the present invention is achieved like this, the Mentholum that adopts the Chinese medicine Herba Menthae or from Herba Menthae, purify and obtain, form compound preparation with Alumen again, after this two medicine ground to form powdery, be made into medicated powder according to a certain percentage, be distributed into every parcel 30～50g, face with preceding and it is dissolved with warm water, promptly can be used for dipping bath slightly after the cold, as long as the skin patient is affected part dipping bath in bath water 20～30 minutes, the effect that can receive anti-inflammation.
Alumen is a kind of conventional Chinese medicine; its composition is mainly aqueous sulfuric acid aluminum potassium; in treating skin disease often it as astringent and protective agent, because of it has vasoconstrictive and bring into play " antiinflammatory " effect, suppress sebaceous gland and sweat gland secretion and inflammation secretions is reduced and bring into play " convergence " and act on.Modern pharmacological research proves, Alumen has significant antibacterial action, golden Fructus Vitis viniferae and Bacillus proteus there is inhibitory action (test tube method), also there is obvious suppression to render a service (paper dish, flat band method) to escherichia coli, bacillus pyocyaneus, anthrax bacillus, dysentery bacterium, Bacillus typhi, paratyphoid fever bacillus, Bacillus proteus and staphylococcus, Candida albicans etc., the strongest to Streptococcus viridans, Hemolytic streptococcus, streptococcus pneumoniae, diphtheria corynebacterium effect; Cattle type Brucella, bordetella pertussis, meningococcus effect are taken second place, hemophilus influenza is not had effect (paper disk method), high concentration Alumen is to human-like (H
37RV) and bacillus tuberculosis bovis inhibitory action is also arranged, research also shows, Alumen also has tangible anti-trichomonas vaginitis effect (Chinese medicine voluminous dictionary, P680), this mechanism of action of Alumen is commonly considered as because it has the effect of intensive solidifying protein, is suppressed even death thereby bacterial growth is grown.Herba Menthae or its extract Mentholum are classified as pruritus to it in treating skin disease, its blood circulation promoting and antiinflammatory, antipruritic etc. acts on now generally acknowledged.Clinical practice in antiinflammatory, antipruritic, pain relieving, alleviate edema etc., studies show that Mentholum is applied to skin because the tip sensor that excites nerve at first produces cold sensation, the sense of burning of slight thorn is arranged subsequently.This moment, skin temperature did not reduce, even slightly raise, and can slowly penetrate Intradermal, cause long hyperemia, and reflexive causes that the deep blood vessel changes, adjust the function of blood vessel, and reach therapeutical effect (Chinese medicine modern study and clinical practice, P683), experiment in vitro also confirms, Herba Menthae is to staphylococcus aureus, Staphylococcus albus, alpha streptococcus, group B streptococcus, micrococcus catarrhalis, the enteritis coccus, shigella flexneri, anthrax bacillus, diphtheria corynebacterium, Bacillus typhi, bacillus pyocyaneus, escherichia coli, Bacillus proteus, Candida albicans all has antibacterial action, research also shows, Herba Menthae is to herpes simplex virus, vaccinia virus, Semliki forest virus and mumps virus all have inhibitory action (Chinese medicine modern study and clinical practice, P683), research in recent years also shows, the Herba Menthae decoct, Mentholum is to dermatophytes such as trichophyton, trichophyton gypseum, acrothesium floccosums etc. all have inhibitory action, wherein Oleum menthae, Mentholum still has bactericidal action preferably.In addition, Oleum menthae, Mentholum also have killing action [Hu Lifang, sterilization and sterilization, 1989,6 (1): 10] to Candida albicans.This seminar also proves, Mentholum has the Transdermal absorption effect that promotes some antibacterials, can strengthen the antibacterial activity of some drugs, Herba Menthae or its extract and Alumen are formed compound preparation, its antibacterial action is strengthened mutually, and antimicrobial spectrum increases, and is used for treating for skin disease, antiphlogistic effects and antipruritic effect are obvious especially, and we are very sure through the clinical observation curative effect.
This project researcher is pressed folk prescription or compound recipe combination to kind of a medicine surplus Herba Menthae, Alumen and other ten respectively, and common skin antibacterial and fungus are studied, and experimental technique and result are as follows:
One, the antibacterial experiment of Alumen, Mentholum
(1), materials and methods
1, medicine: Alumen (aqueous sulfuric acid aluminum potassium 92%), Folium Menthae extract (containing Mentholum 99%), magnificent cottonrose hibiscus bath powder are provided by Medicines Science and Technology Development Center, Guangdong Medical College (.
2, strain: (1) penicillium; (2) penicillium chrysogenum; (3) penicillium citrinum; (4) acrothesium floccosum; (5) sporotrichum schenckii; (6) Candida albicans; (7) Cryptococcus histolyticus; (8) microsporon gypseum; (9) Microsporum ferrugineum; More than nine kinds provide by the Norman Bethune Medical University; (1) staphylococcus aureus; (11) staphylococcus epidermidis; (12) colon bacillus; (13) Bacillus proteus; (14) bacillus subtilis.Above four strains is provided by the calibrating of Ministry of Public Health pharmaceutical biological product.Slant medium preservation, standby is recovered, gone down to posterity, puts to the strain of above-mentioned reference culture.
3, culture medium: the plain agar culture medium, be used for the cultivation of antibacterial, sabouraud's agar is used for the cultivation of fungus.Add different pharmaceutical in culture medium, be used for antibacterial tests, used drug ratios, concentration are decided by requirement of experiment.
4, antibacterial tests: with the reference culture of antibacterial and fungus, be inoculated in respectively on the medicament selection flat board that contains variable concentrations, and be matched group with the plating medium that does not contain medicine.Fungus is put 26 ℃ of cultivations, and respectively at 72 hours with 1 when week observed and the record result, antibacterial was put 37 ℃ of incubators and cultivates, and observed and the record result judgement MIC at 24 hours and 72 hours.To the growth negative patient, to scrape and get its culture medium inoculated trace transferred species in not containing on the medicine flat board or on the inclined-plane, transferred species is still given birth to the elder, shows that this medicine is antibacterial, does not give birth to the elder and is sterilization.
4.1 Alumen, Mentholum list agent antibacterial tests.Make two kinds of medicines to be measured of variable concentrations and control drug (fungus---miconazole nitrate respectively, antibacterial---chloromycetin) Sha Shi slant medium and plain agar plating medium, 14 kinds of bacterium that inoculation is selected, put the incubator of corresponding humidity, the growing state of each bacterium of observed and recorded is judged the MIC of various medicines to different strains.
4.2 the antibacterial tests of the Alumen+Mentholum of different proportion compatibility, with the MIC (the judgement main reference dermatophytosis of this value is also taken into account all the other bacterial strains) of Alumen and Mentholum respectively in the ratio compatibility of 1: 1 and 5: 1,10: 1, with double concentration is starting point, the two-fold dilution becomes descending series medicine flat board and inclined-plane, and the inoculation different strains is observed the growth phenomenon.
(2), experimental result
1, Alumen, the agent of Mentholum list all have in various degree bacteriostasis to various funguses and antibacterial, see table 1 and table 2 for details.
Table 1 Mentholum antibacterial tests result
| Drug level mg/ml | 1.0 | 0.2 | 0.04 | 0.008 |
| Penicillium | - | - | + | + |
| Penicillium chrysogenum | - | - | + | + |
| Penicillium citrinum | - | - | + | + |
| Acrothesium floccosum | - | - | + | + |
| Sporotrichum schenckii | - | - | + | + |
| Candida albicans | - | - | + | + |
| Cryptococcus histolyticus | - | - | + | + |
| Microsporon gypseum | - | - | + | + |
| Microsporum ferrugineum | - | + | + | + |
| Staphylococcus aureus | - | + | + | + |
| Staphylococcus epidermidis | - | - | - | + |
| Colon bacillus | - | - | + | + |
| Bacillus proteus | - | - | + | + |
| Bacillus subtilis | - | - | - | + |
Table 2 Alumen antibacterial tests result
| Drug level mg/ml | 12.5 | 6.25 | 3.125 | 1.56 | 0.78 |
| Penicillium | - | - | - | + | + |
| Penicillium chrysogenum | - | - | - | + | + |
| Penicillium citrinum | - | - | - | - | + |
| Acrothesium floccosum | - | - | - | + | + |
| Sporotrichum schenckii | - | - | + | + | + |
| Candida albicans | - | - | - | + | + |
| Cryptococcus histolyticus | - | - | + | + | + |
| Microsporon gypseum | - | - | + | + | + |
| Microsporum ferrugineum | - | - | + | + | + |
| Staphylococcus aureus | - | - | - | + | + |
| Staphylococcus epidermidis | - | - | - | - | + |
| Colon bacillus | - | - | - | - | + |
| Bacillus proteus | - | - | - | - | + |
| Bacillus subtilis | - | - | - | - | + |
In table 1 as can be seen Alumen to the MIC of penicillium sp mushroom between 0.78～1.56mg/ml, for the MIC of deep fungal (Candida albicans, Cryptococcus histolyticus and sporotrichum schenckii) between 1.56～3.12mg/ml; And for dermatophytosis (acrothesium floccosum, microsporon gypseum, Microsporum ferrugineum) MIC is 3.125mg/ml, is 0.78mg/ml for the MIC of common bacteria (staphylococcus aureus, staphylococcus epidermidis, colon bacillus, Bacillus proteus, bacillus subtilis).The agent of Mentholum list to the MIC of penicillium sp mushroom between 0.04～0.2mg/ml; MIC to deep fungal is 0.04mg/ml; And between the MIC 0.04～0.2mg/g to dermatophytosis, between 0.008～0.2mg/ml, wherein golden Fructus Vitis viniferae tolerance is the strongest to the MIC of common bacteria.Staphylococcus epidermidis and bacillus subtilis are comparatively responsive.Control drug also shows bacteriostasis in various degree.
2, press the antifungal and the bacteria test result of the Alumen+Mentholum of different proportion compatibility use.Single agent antibacterial tests result shows: Alumen is A=3.125mg/ml to the MIC of dermatophytes, and the MIC of deep fungal and common bacteria then is lower than this value, and Mentholum is B=0.2mg/ml to the MIC of dermatophytes; MIC to other bacterial strains also is lower than this value.The A of different shares is merged use with the B of different shares, do further further investigation.
Experimental result shows, after the MIC of Alumen and Mentholum merged (3.125: 0.2) in 1: 1 ratio, MIC to the penicillium sp mushroom has reduced a multiple proportions gradient, the minimal inhibitory concentration of mixture is equivalent to 1/2nd of single agent, fungistatic effect to three kinds of dermatophytosises, mixture also has enhancing in various degree, wherein, bacteriostasis to acrothesium floccosum significantly strengthens than Alumen and the agent of Mentholum list, consumption all is reduced to 1/4th of former level, and the microsporon gypseum consumption is equivalent to 1/2nd of single agent; The Microsporum ferrugineum mixture is not shown potentiation.Mixture is basic similar to the agent of Mentholum list to the deep fungal fungistatic effect, but the Alumen consumption has reduced by 4 times.Mixture also has potentiation to the effect of common bacteria except that golden Portugal and table Portugal.The potentiation amplitude is that the more single agent of MIC reduces a dilution gradient.More single agent use also has potentiation to mixture to the effect of penicillium sp mushroom.Amplitude is that MIC reduces by 1 times.
When the ratio with Alumen rises to 5 times (5A: 1B 15.6: 0.2), mixture shows as bactericidal action to penicillium, when the amount ratio of Alumen and Mentholum is (1.95: 0.025), wherein the consumption of Alumen and single agent are used similarly, and the consumption of Mentholum reduces to original 1/4th; Mixture is 1.95: 0.025 to the MIC of acrothesium floccosum, the all more single agent of two survival doses reduces 1～2 times, have than obvious synergistic effect, but mixture is not better than 1: 1 ratio mixture to the bacteriostasis of microsporon gypseum and Microsporum ferrugineum, not obviously is better than single agent yet.Mixture was different to the bacteriostasis of three kinds of deep fungals in 5: 1, and is stronger to the Cryptococcus histolyticus effect, and the mixture consumption is equivalent to 1/4th and ten sixths of single agent consumption respectively for (1: 0.013).When analyzing 10: 1 mixture, because the Alumen ratio is too high, so also be to show as Alumen list agent effect basically to the effect of antibacterial and fungus.
Two, the antibacterial experiment of magnificent cottonrose hibiscus bath powder
According to above-mentioned test, we have carried out multifactorial orthogonal test to Alumen and Mentholum, seek the optimal proportion that this two medicine cooperates, by big quantity research and comprehensive each factorial analysis, we have found that Alumen and Mentholum are in 25～35: best results during 0.2～1 ratio proportioning, better to above-mentioned 14 kinds of antibacterial antibacterial actions, its comprehensive function has surpassed two medicines and has divided other effect, the factor of our comprehensive each side is considered, we have selected intermediary ratio to be made into magnificent cottonrose hibiscus bath powder, the ratio that is Alumen and Mentholum is with 30～32: 0.3～0.6 is the prescription foundation, we are mixed with compound preparation China cottonrose hibiscus bath powder with this ratio, carry out drug sensitive test and toxicity test again, the result is as follows:
1, the antibacterial action of magnificent cottonrose hibiscus bath powder clinical practice concentration research
Magnificent cottonrose hibiscus bath powder is dissolved in the clinical practice concentration in 4 kilograms the warm water by every parcel 30g, carried out antibacterial experiment, experimental result shows that this product has the obvious sterilization effect to following antibacterial and fungus: (1) staphylococcus aureus; (2) staphylococcus epidermidis; (3) colon bacillus; (4) Bacillus proteus; (5) bacillus subtilis; (6) penicillium; (7) penicillium chrysogenum; (8) acrothesium floccosum; (9) sporotrichum schenckii; (10) Candida albicans; (11) microsporon gypseum; (12) penicillium citrinum; (13) Cryptococcus histolyticus.
This product is invalid to Microsporum ferrugineum, but when concentration reaches 0.8%, when promptly every bag 30g is dissolved in 2kg warm water, then Microsporum ferrugineum is also had tangible bacteriostasis.
2, the bacteriostasis after magnificent cottonrose hibiscus bath powder clinical practice liquid dilutes 2 times
Magnificent cottonrose hibiscus bath powder is carried out bacteriostatic experiment by one times of clinical practice amount redilution (30g is dissolved in the 8kg warm water), the result shows, in to above-mentioned 13 kinds of effective bacterium, except that sporotrichum schenckii, microsporon gypseum, staphylococcus aureus, all the other 10 kinds of test organismss are still had significant antibacterial action.
3, the bacteriostasis after magnificent cottonrose hibiscus bath powder clinical practice liquid dilutes 4 times
China's cottonrose hibiscus bath powder still has significant bactericidal action by 4 times (30g is dissolved in 16 kilograms of warm water) of clinical practice amount dilution to Cryptococcus histolyticus, staphylococcus epidermidis, colon bacillus, Bacillus proteus, bacillus subtilis.
4, the bacteriostasis after magnificent cottonrose hibiscus bath powder clinical practice liquid dilutes 8 times
China's cottonrose hibiscus bath powder still has significant bactericidal action by 8 times (30g is dissolved in 32 kilograms of warm water) of clinical practice amount dilution to colon bacillus, Bacillus proteus.
Three, the studies on acute toxicity of magnificent cottonrose hibiscus bath powder report
China's cottonrose hibiscus bath powder to skin nonirritant and anaphylaxis, has certain zest to the skin injury place as disinfectant for external use when skin soaks, and certain local cool sense is arranged.
The test of white mice acute oral toxicity shows, give (20 every group of 40 white mice respectively with magnificent cottonrose hibiscus bath powder clinical practice amount and 15 times of concentration surpassing clinical consumption, male and female half and half) gastric infusion (0.75g/kg and 11.25g/kg), two groups 40 equal non-toxic reactions of mice of result, observe all survivals in 7 days, illustrated that this product is higher than 11.25g/kg to the oral minimum lethal dose of mice.As only being used for the external dipping bath, can think to belong to the minimum or nontoxic substantially level of toxicity.
Four, the prescription adjustment of magnificent cottonrose hibiscus bath powder
Studies show that, China's cottonrose hibiscus bath powder can add into sulfur, sulfur is pulverized and is powdery, 8～12% ratio in total amount adds in the magnificent cottonrose hibiscus bath powder, can obtain better curative effect, it is good to dermatosis curative effect spies such as scabies that this bathes agent, and further research shows that also the optimal proportion of magnificent cottonrose hibiscus bath powder is that the ratio of sulfur, Mentholum, Alumen is 2～4: 0.5: 30.
Five, the application example of magnificent cottonrose hibiscus bath powder:
Get Mentholum and Alumen etc. and pulverize, be made into magnificent cottonrose hibiscus bath powder as stated above, be distributed into every bag 30g, face with before adding stirring and dissolving in 4 kilograms of 40～50 ℃ of hot water, soak the affected part, every day one is to secondary, logotype 5～7 days, remission or disappearance such as can make skin affected part inflammation, scratch where it itches.This product is attached institute department of dermatologry clinical observation 1000 routine patients through the court, tentatively prove this product to scabies, acne, psoriasis, seborrheic dermatitis, neurodermatitis, eczema, fill the air scratch where it itches disease, pruritus, drug eruption, prurigo, pityriasis rosea, urethritis, scrotitis, vulvitis, perianal dermatitis, perineal position dermatitis, gonorrhea and gonorrhea sexuality of rubescent dermatitis, general and dye etc. significant curative effect is all arranged.Effective percentage reaches 98%.
Claims (3)
1, a kind of external-use bathing lotion with anti-inflammation is characterized in that, be made up of Mentholum and Alumen, and the optimal proportion of Mentholum and Alumen is 0.2～1: 25～35.
2, a kind of external-use bathing lotion with anti-inflammation is characterized in that, described bath agent contains bath agent as claimed in claim 1 and sulfur, and sulfur is to be ground into behind the fine powder in 8～12% ratio to add among this bath powder.
5, as claims 2 described external-use bathing lotions with anti-inflammation, it is characterized in that, is this bath agent sulfur, and the formula proportion of Mentholum and Alumen is 2～4: 0.5: 30.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB981223494A CN1160055C (en) | 1998-11-11 | 1998-11-11 | External-use bathing lotion with antibiotic and anti-inflammatory functions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB981223494A CN1160055C (en) | 1998-11-11 | 1998-11-11 | External-use bathing lotion with antibiotic and anti-inflammatory functions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1251295A CN1251295A (en) | 2000-04-26 |
| CN1160055C true CN1160055C (en) | 2004-08-04 |
Family
ID=5227744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB981223494A Expired - Fee Related CN1160055C (en) | 1998-11-11 | 1998-11-11 | External-use bathing lotion with antibiotic and anti-inflammatory functions |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1160055C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002062354A1 (en) * | 2001-02-08 | 2002-08-15 | The Procter & Gamble Company | Allergen neutralization compositions containing aluminum ions |
-
1998
- 1998-11-11 CN CNB981223494A patent/CN1160055C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1251295A (en) | 2000-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5571520A (en) | Molecular crystal redox device for pharmaceuticals | |
| US20020136750A1 (en) | Acidified nitrite as an antimicrobial agent | |
| CN107184427A (en) | A kind of cooperative compositions and application containing polyglutamic acid and hyaluronic acid | |
| US5837254A (en) | Method of treating candida and cryptococcus fungal infections by administering gentian | |
| CN108553355A (en) | A kind of compound houttuynin oral bacteriostasis fresh and cool spray and preparation method thereof | |
| CN1111984A (en) | Bath lotion series with anti-inflammatory, antipruritic and antibiotic functions | |
| CN114028546A (en) | Composite polypeptide sterilization preparation and preparation method and application thereof | |
| CN118203563A (en) | Application of quinone compounds in preventing and treating pathogenic bacteria of dairy cow mastitis | |
| CN101829130A (en) | Compound resveratrol anti-inflammatory and itching relieving medicament combination and purpose thereof | |
| CN113398237B (en) | A kind of traditional Chinese medicine composition for antibacterial, antipruritic and antidandruff and preparation method thereof | |
| CN111803624A (en) | Skin antibacterial gel preparation containing transfer factor and preparation method thereof | |
| CN1160055C (en) | External-use bathing lotion with antibiotic and anti-inflammatory functions | |
| HK1045813A1 (en) | Non-solid composition for local application comprising glycerol and alchemilla vulgaris extract | |
| WO2021258654A1 (en) | Silver ion antibacterial hand sanitizer, preparation method therefor, and application thereof | |
| CN101332286B (en) | Traditional Chinese medicine composition for treating skin disease and preparation method thereof | |
| CN108785383B (en) | Antibacterial gynecological external medicine composition and preparation method and application thereof | |
| US7704976B2 (en) | Use of N-acetyl-D-glucosamine for preparing medicines for urogenital tract infection's treatment and prevention | |
| Тikhonov et al. | Creation of pharmaceutical compositions with the antifungal, antimicrobial and keratolytic activity | |
| CN107174535A (en) | A kind of hyaluronic acid compositions and application with the transdermal reparation effect of anti-inflammatory | |
| CN103251636A (en) | Medicament for treating Candida infections and diseases caused by Candida, and preparation method thereof | |
| CN106109588A (en) | A kind of spray treating tinea pedis and preparation method thereof | |
| KR20030092519A (en) | Composition for improving or preventing of allergic dermatological diseases | |
| CN101361938A (en) | Kibe paste containing natural zingiber oil | |
| CN106236835A (en) | A kind of plants essential oil spray and its preparation method and application | |
| CN112386539A (en) | Shampoo product with effects of recovering scalp itching and desquamation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |